menu
    • menu

    Company profile for Recludix Pharma

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets by integrating custom-generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and a proprietary screening tool to ensure selectivity. Recludix is employing this approach first in the development of SH2 domain inhibitors. The company is advancing another...
    Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets by integrating custom-generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and a proprietary screening tool to ensure selectivity. Recludix is employing this approach first in the development of SH2 domain inhibitors. The company is advancing another program with an undisclosed non-STAT SH2 domain target that also plays a significant role in both cancer and autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Recludix PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3525 John Hopkins Court, Suite 150 San Diego, CA 92121
    Telephone
    Telephone
    +1 8582585445
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://recludixpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/recludix-pharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Recludix Pharma Clears FDA For REX-8756, Oral STAT6 Inhibitor
    Recludix Pharma Clears FDA For REX-8756, Oral STAT6 Inhibitor

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206147/0/en/Recludix-Pharma-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-REX-8756-an-Oral-STAT6-Inhibitor-to-Enter-into-the-Clinic.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    Recludix Pharma To Present at 2 Investor Conferences In November
    Recludix Pharma To Present at 2 Investor Conferences In November

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179171/0/en/Recludix-Pharma-to-Present-at-Two-Investor-Conferences-in-November.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Recludix Pharma to Speak at Stifel 2025 Immunology Forum
    Recludix Pharma to Speak at Stifel 2025 Immunology Forum

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148857/0/en/Recludix-Pharma-to-Present-at-the-Stifel-2025-Virtual-Immunology-and-Inflammation-Forum.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    Recludix Pharma Promotes Dr. Brian to Chief Scientific Officer
    Recludix Pharma Promotes Dr. Brian to Chief Scientific Officer

    14 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/14/3114692/0/en/Recludix-Pharma-Announces-Strengthening-of-Leadership-Team-Including-Promotion-of-Dr-Brian-Hodous-to-Chief-Scientific-Officer.html

    GLOBENEWSWIRE
    14 Jul 2025
    Share Share
    Recludix Names STAT6 Inhibitor Candidate Under Sanofi Deal
    Recludix Names STAT6 Inhibitor Candidate Under Sanofi Deal

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091698/0/en/Recludix-Pharma-Announces-Development-Candidate-Nomination-of-First-in-Class-Oral-STAT6-Inhibitor-for-Inflammatory-Diseases-and-Achievement-of-Significant-Milestone-Under-Collabora.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share
    Recludix Pharma Shows STAT6 Inhibitor Efficacy in Asthma Model
    Recludix Pharma Shows STAT6 Inhibitor Efficacy in Asthma Model

    19 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/19/3083940/0/en/Recludix-Pharma-Presents-Data-Demonstrating-Potent-Efficacy-and-High-Selectivity-of-a-STAT6-Inhibitor-in-Preclinical-Asthma-Model.html

    GLOBENEWSWIRE
    19 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search